We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$984M
1-Year Est. Return
72.08%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+72.08%
3 Year Est. Return
+124.02%
5 Year Est. Return
+117.81%
10 Year Est. Return
+397.76%
AUM
$439M
AUM Growth
-$24.1M
(-5.2%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
302
New
33
Increased
60
Reduced
85
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDP
Hortonworks, Inc.
HDP
|
+$8.35M |
| 2 |
Rockwell Automation
ROK
|
+$7.14M |
| 3 |
Quanta Services
PWR
|
+$6.5M |
| 4 |
Arista Networks
ANET
|
+$6.03M |
| 5 |
Akebia Therapeutics
AKBA
|
+$4.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$7.95M |
| 2 |
Palo Alto Networks
PANW
|
+$7.12M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$6.49M |
| 4 |
SEE
Sealed Air
SEE
|
+$5.16M |
| 5 |
Universal Health Services
UHS
|
+$3.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.41% |
| 2 | Industrials | 16.55% |
| 3 | Technology | 15.76% |
| 4 | Healthcare | 13.52% |
| 5 | Materials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Qualys
QLYS
$6.03B
| $9.99M | 2.27% |
137,267
-11,282
| -8% | -$778K |
|
|
HDP
2
DELISTED
Hortonworks, Inc.
HDP
| $9.38M | 2.14% |
460,703
+424,220
| +1,163% | +$8.35M |
|
3
Curtiss-Wright
CW
$21B
| $8M | 1.82% |
59,247
-854
| -1% | -$112K |
|
|
PFPT
4
DELISTED
Proofpoint, Inc.
PFPT
| $7.37M | 1.68% |
64,875
-6,586
| -9% | -$699K |
|
|
TIF
5
DELISTED
Tiffany & Co.
TIF
| $7.33M | 1.67% |
75,000
+10,000
| +15% | +$1.03M |
|
6
PayPal
PYPL
$48.6B
| $6.61M | 1.51% |
87,092
-12,979
| -13% | -$1.03M |
|
7
Neurocrine Biosciences
NBIX
$16.1B
| $6.56M | 1.5% |
79,156
-9,990
| -11% | -$844K |
|
|
8
Rockwell Automation
ROK
$47.6B
| $6.55M | 1.49% |
+37,619
| New | +$7.14M |
|
9
Thermo Fisher Scientific
TMO
$229B
| $6.2M | 1.41% |
30,033
-98
| -0.3% | -$20.6K |
|
|
10
Quanta Services
PWR
$93.2B
| $6.15M | 1.4% |
+179,094
| New | +$6.5M |
|
|
KSU
11
DELISTED
Kansas City Southern
KSU
| $5.88M | 1.34% |
53,544
-1,821
| -3% | -$197K |
|
|
12
Arista Networks
ANET
$241B
| $5.71M | 1.3% |
+357,728
| New | +$6.03M |
|
13
Darling Ingredients
DAR
$10.4B
| $5.67M | 1.29% |
327,959
-6,172
| -2% | -$112K |
|
14
Sensata Technologies
ST
$6.12B
| $5.54M | 1.26% |
106,811
-1,325
| -1% | -$70.6K |
|
15
Trimble
TRMB
$14B
| $5.4M | 1.23% |
150,384
-10,765
| -7% | -$434K |
|
|
IMPV
16
DELISTED
Imperva, Inc.
IMPV
| $5.32M | 1.21% |
122,814
-2,197
| -2% | -$98.7K |
|
17
Avient
AVNT
$3.94B
| $5.24M | 1.19% |
123,197
+630
| +0.5% | +$27.2K |
|
18
Labcorp
LH
$26.9B
| $5.13M | 1.17% |
36,938
-1,383
| -4% | -$203K |
|
19
FMC
FMC
$1.63B
| $5.13M | 1.17% |
77,269
-6,315
| -8% | -$471K |
|
20
BioMarin Pharmaceuticals
BMRN
$12.9B
| $5.07M | 1.15% |
62,517
-2,416
| -4% | -$207K |
|
|
LJPC
21
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $5M | 1.14% |
167,825
-828
| -0.5% | -$26.7K |
|
22
Ingredion
INGR
$6.41B
| $4.99M | 1.14% |
38,696
-1,581
| -4% | -$212K |
|
23
Carlisle Companies
CSL
$13.7B
| $4.94M | 1.13% |
47,334
-1,972
| -4% | -$216K |
|
24
MDU Resources
MDU
$4.15B
| $4.83M | 1.1% |
451,443
-33,758
| -7% | -$343K |
|
|
KS
25
DELISTED
KapStone Paper and Pack Corp.
KS
| $4.63M | 1.06% |
135,000
| – | – |
|
Similar funds
LI
CPBTD
APFP
CVM
SAA
MHIC
JIR
FPGK
Stanley-Laman Group's Q1 2018 Portfolio in Review
As of Q1 2018, Stanley-Laman Group held 302 positions worth $439M, down 5.2% from $463M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Stanley-Laman Group's Q1 2018 filing shows 33 new, 60 increased, 85 reduced and 40 closed positions. Its largest new stake was Rockwell Automation: 37,619 shares worth $6.55M. The largest sale was Acadia Pharmaceuticals, an estimated $7.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
- Stanley-Laman Group's largest Q1 2018 buy was Rockwell Automation: 37,619 shares worth $6.55M.
- Stanley-Laman Group added most to Hortonworks, Inc. in Q1 2018, an estimated $8.35M increase.
- Stanley-Laman Group's biggest Q1 2018 reduction was Acadia Pharmaceuticals, cutting an estimated $7.95M.
- Stanley-Laman Group fully exited Palo Alto Networks in Q1 2018, selling an estimated $7.12M.
- Stanley-Laman Group's ten largest holdings make up 17% of its $439M portfolio in Q1 2018.
- Stanley-Laman Group opened 33 new positions and closed 40 in Q1 2018.
- Stanley-Laman Group's portfolio value fell 5.2% quarter-over-quarter to $439M.
Based on Stanley-Laman Group's 13F filing for Q1 2018, filed 1 May 2018.